Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors
Part of paid clinical trials in Orange, California.
- Sponsor
- University of California, Irvine
- Study ID
- NCT07628634
- Phase
- EARLY_PHASE1
- Status
- Recruiting
Conditions
- Adenocarcinoma
- Basal Cell Carcinoma
- Ductal Carcinoma
- Endocrine Tumor
- Ewing Sarcoma
- Germ Cell Tumor
- Glioma
- Leiomyosarcoma
- Lymphoma
- Melanoma
- Osteosarcoma
- Rhabdomyosarcoma
- Soft Tissue Sarcoma
- Squamous Cell Carcinoma
- Transitional Cell Carcinoma
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Methionine-Reduced Diet — OTHERNormal diet days 1-3 and 8, Methionine-Reduced Diet days 4-7, standard of care cancer treatment initiation on day 8.
Study Details
This is a pilot clinical trial determining the effect of a Methionine-reduced diet on serum levels in subjects with solid tumors. These are subjects who will receive systemic standard of care cancer therapy.
Key Dates
- Start date
- May 1, 2026
- Status verified
- Jun 2026
- Primary completion
- May 1, 2027
- Completion
- May 1, 2028
Study Design
- Enrollment
- 25 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: Single Arm: Methionine-Reduced Diet
Primary Outcome Measure
Adherence to Diet [ Time Frame: 8 days ]
Central Contacts
- Chao Family Comprehensive Cancer Center University of California, Irvine877-827-8839
- University of California Irvine Medical
Locations (1)
| Facility | City | State | ZIP |
|---|---|---|---|
| Chao Family Comprehensive Cancer Center, University of California, Irvine | Orange | California | 92868 |
Find similar trials in Orange, CA
By condition
By specialty
Related Studies
- Bone Marrow Grafting for Leukemia and LymphomaEnrolling By Invitation · Stanford University · Stanford, California
- Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer TreatmentRecruiting · Children's Oncology Group · Birmingham, Alabama
- Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)PHASE3 · Recruiting · Advenchen Laboratories, LLC · Phoenix, Arizona
- Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell TumorsPHASE3 · Recruiting · Children's Oncology Group · Birmingham, Alabama